Fugl-Meyer Assessment (FMA): Stroke Recovery Measure
The Fugl-Meyer Assessment evaluates motor recovery in stroke survivors. Therapists use this performance-based test to check movement and balance, helping guide rehabilitation plans.
Fugl-Meyer Assessment (FMA)
The Fugl-Meyer Assessment (FMA) evaluates recovery following a stroke by measuring motor function, balance, sensation, and joint range. This performance-based index helps clinicians track impairment levels and guide rehab. It's a standard tool for assessing post-stroke hemiplegia and monitoring patient progress.
Category
Disease
Source
What is Fugl-Meyer Assessment (FMA)
The Fugl-Meyer Assessment (FMA) is a key tool for checking stroke recovery progress. It measures sensorimotor impairment in patients living with hemiplegia. This scale evaluates five specific domains covering motor function, sensory loss, balance qualities, joint range of motion, and joint pain levels to ensure nothing is missed. Clinicians score items on a three point ordinal scale where zero means the patient cannot do the task and two means they do it fully. The total maximum score sits at 226, though the motor section is often used alone with a max of 100 points. It takes roughly 30 minutes to finish and is commonly used in clinical trials plus rehabilitation settings. Therapists value the FMA because it tracks changes over time really well. This helps teams plan better treatments and clearly see how much function a patient has regained after a stroke event.
The Fugl Meyer Assessment can be scored using one main approach based on a three point ordinal scale. Items are rated 0 if the patient cannot perform the task, 1 for partial completion, and 2 for full performance. You tally these points across five domains covering motor function, sensory, balance, joint range of motion, and joint pain. The maximum total score hits 226, though it is common to focus on the motor domain's 100 points to track stroke recovery. This helps physios spot specific impairments and plan rehab.
Advantages
.svg){kind=icon}
Measures healthcare intervention results systematically.
.svg){kind=icon}
Strengthens evidence through systematic measurement approaches.
Develops personalised strategies based on assessment data.
.svg){kind=icon}
Provides consistent measurements for clinical research.
.png){kind=icon}
Related Instruments
Screens for neuropathic pain components.
Predicts long-term disability risk in musculoskeletal pain.
Assesses symptoms and function in lumbar spinal stenosis.
Collect Fugl-Meyer Assessment data with WeGuide, the all in one patient engagement platform
.jpg)
Support Your patient in no time - all under your own brand
Our platform combines the knowledge of 100+ digital health solutions built, letting you easily build your patient engagement app for research or clinical use. Collect PROMs, support patients on waiting lists, or gather vital signs data. This is how:
Learn More.png){kind=icon}
Program Builder
.png)
.png){kind=icon}
Whitelabelling
.svg)
.svg)
.png){kind=icon}
Turn on components, dependent on your usecase
.svg)
.png){kind=icon}
Support The Full Journey
.png)
.png)
%20(1).png)
.png)
It’s your turn
Every WeGuide project, saves researchers and clinicians - 9 months and $450,000 - creating impactful digital health solutions.
